Cite
APA Citation
Luo, J., Tian, J., Chou, F., Lin, C., Xing, E. Z., Zuo, L., Niu, Y., Yeh, S., & Chang, C. (2019). targeting the androgen receptor (AR) with AR degradation enhancer ASC-J9® led to increase docetaxel sensitivity via suppressing the p21 expression. Cancer letters, 444, 35–44. http://access.bl.uk/ark:/81055/vdc_100076783375.0x000040